Why and how the work of Motor Neurone Disease Associations matters before and during bereavement: a consumer perspective.
Motor Neurone Disease Associations
bereavement support
consumer perspective
emotional support
end-of-life care
family caregivers
motor neurone disease
motor neurone disease advisors
practical support
public health approach
Journal
Palliative care and social practice
ISSN: 2632-3524
Titre abrégé: Palliat Care Soc Pract
Pays: United States
ID NLM: 101754997
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
02
2021
accepted:
24
03
2021
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
10
6
2021
Statut:
epublish
Résumé
Studies on the experiences of consumers with Motor Neurone Disease Associations at end of life and bereavement are lacking, and their role and capability within the broader sectors of health and disability are unknown. To ascertain the experiences and views of bereaved motor neurone disease caregivers with Motor Neurone Disease Associations about service gaps and needed improvements before and during bereavement and to propose a model of care that fits with consumer preferences and where Motor Neurone Disease Associations are effective enablers of care. A national bereavement survey was facilitated in 2019 by all Motor Neurone Disease Associations in Australia. A total of 363 respondents completed the section on support provided by Motor Neurone Disease Associations. A mixed-method design was used. Respondents were generally positive about support received before bereavement (73-76%), except for emotional support (55%). Positive experiences related to the following: information, equipment advice/provision, advocacy/linking to services, showing empathy/understanding, personal contact and peer social support. Negative experiences included lack of continuity in case management and contact, perceived lack of competence or training, lack of emotional support and a lack of access to motor neurone disease services in rural areas. Suggested improvements were as follows: more contact and compassion at end of life and postdeath; better preparation for end of life; option of discussing euthanasia; providing referrals and links for counseling; access to caregiver support groups and peer interaction; provision of a genuine continuum of care rather than postdeath abandonment; guidance regarding postdeath practicalities; and more access to bereavement support in rural areas. This study provides consumer perspectives on driving new or improved initiatives by Motor Neurone Disease Associations and the need for a national standardised approach to training and service delivery, based on research evidence. A public health approach to motor neurone disease end-of-life care, of international applicability, is proposed to address the needs and preferences of motor neurone disease consumers, while supporting the capability of Motor Neurone Disease Associations within a multidisciplinary workforce to deliver that care.
Sections du résumé
BACKGROUND
BACKGROUND
Studies on the experiences of consumers with Motor Neurone Disease Associations at end of life and bereavement are lacking, and their role and capability within the broader sectors of health and disability are unknown.
OBJECTIVES
OBJECTIVE
To ascertain the experiences and views of bereaved motor neurone disease caregivers with Motor Neurone Disease Associations about service gaps and needed improvements before and during bereavement and to propose a model of care that fits with consumer preferences and where Motor Neurone Disease Associations are effective enablers of care.
METHODS
METHODS
A national bereavement survey was facilitated in 2019 by all Motor Neurone Disease Associations in Australia. A total of 363 respondents completed the section on support provided by Motor Neurone Disease Associations. A mixed-method design was used.
RESULTS
RESULTS
Respondents were generally positive about support received before bereavement (73-76%), except for emotional support (55%). Positive experiences related to the following: information, equipment advice/provision, advocacy/linking to services, showing empathy/understanding, personal contact and peer social support. Negative experiences included lack of continuity in case management and contact, perceived lack of competence or training, lack of emotional support and a lack of access to motor neurone disease services in rural areas. Suggested improvements were as follows: more contact and compassion at end of life and postdeath; better preparation for end of life; option of discussing euthanasia; providing referrals and links for counseling; access to caregiver support groups and peer interaction; provision of a genuine continuum of care rather than postdeath abandonment; guidance regarding postdeath practicalities; and more access to bereavement support in rural areas.
CONCLUSION
CONCLUSIONS
This study provides consumer perspectives on driving new or improved initiatives by Motor Neurone Disease Associations and the need for a national standardised approach to training and service delivery, based on research evidence. A public health approach to motor neurone disease end-of-life care, of international applicability, is proposed to address the needs and preferences of motor neurone disease consumers, while supporting the capability of Motor Neurone Disease Associations within a multidisciplinary workforce to deliver that care.
Identifiants
pubmed: 34104885
doi: 10.1177/26323524211009537
pii: 10.1177_26323524211009537
pmc: PMC8072839
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26323524211009537Informations de copyright
© The Author(s), 2021.
Déclaration de conflit d'intérêts
Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.
Références
Int J Nurs Stud. 2016 Dec;64:32-41
pubmed: 27684320
Death Stud. 2020 Mar 19;:1-9
pubmed: 32189580
PLoS One. 2017 Oct 4;12(10):e0184750
pubmed: 28977013
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Feb;22(1-2):12-22
pubmed: 32909457
PLoS One. 2019 Mar 7;14(3):e0213367
pubmed: 30845193
Palliat Med. 2014 Apr;28(4):318-25
pubmed: 24637571
Health Sociol Rev. 2020 Jul;29(2):211-225
pubmed: 33411656
Neurodegener Dis Manag. 2020 Apr;10(2):95-101
pubmed: 32352344
Muscle Nerve. 2020 Jun;61(6):682-691
pubmed: 32297678
Palliat Med. 2018 Jan;32(1):257-267
pubmed: 28627971
PLoS One. 2015 Apr 07;10(4):e0123012
pubmed: 25849348
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):555-561
pubmed: 28678542
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Palliat Care Soc Pract. 2020 Jul 2;14:2632352420935130
pubmed: 32656530
Psychooncology. 2017 Apr;26(4):484-492
pubmed: 26661137
Amyotroph Lateral Scler. 2012 Jan;13(1):11-24
pubmed: 21879834
Int J Geriatr Psychiatry. 2014 Dec;29(12):1221-9
pubmed: 24955568
Rheumatol Adv Pract. 2020 Jan 28;4(1):rkaa003
pubmed: 32211579
BMJ Support Palliat Care. 2013 Dec;3(4):383-8
pubmed: 24950517
BMC Palliat Care. 2015 May 03;14:22
pubmed: 25935715
Health Soc Care Community. 2018 Jul;26(4):556-563
pubmed: 29479773
J Med Eng Technol. 2014;39(7):404-10
pubmed: 26453038
Palliat Support Care. 2017 Feb;15(1):32-43
pubmed: 27173737
J Med Ethics. 2021 Jan 5;:
pubmed: 33402428
J Pain Symptom Manage. 2018 Feb;55(2):368-378
pubmed: 29030206
Palliat Support Care. 2018 Apr;16(2):228-237
pubmed: 28829002
BMJ Open. 2019 Dec 18;9(12):e032364
pubmed: 31857308
Am J Hosp Palliat Care. 2018 Jun;35(6):847-851
pubmed: 29034688
Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Dec;2(4):203-8
pubmed: 11958732
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(7-8):593-605
pubmed: 32668960
Health Expect. 2018 Aug;21(4):707-713
pubmed: 29512248